[PDF][PDF] Visual Side Effects Linked to Sildenafil Consumption: An Update. Biomedicines 2021, 9, 291

E Ausó, V Gómez-Vicente, G Esquiva - 2021 - core.ac.uk
Phosphodiesterase type 5 (PDE5) inhibitors such as Viagra®(sildenafil citrate) have
demonstrated efficacy in the treatment of erectile dysfunction (ED) by inducing cyclic …

Visual side effects linked to sildenafil consumption: an update

E Ausó, V Gómez-Vicente, G Esquiva - Biomedicines, 2021 - mdpi.com
Phosphodiesterase type 5 (PDE5) inhibitors such as Viagra®(sildenafil citrate) have
demonstrated efficacy in the treatment of erectile dysfunction (ED) by inducing cyclic …

Visual Side Effects Linked to Sildenafil Consumption: An Update

E Ausó-Monreal, V Gómez-Vicente, G Esquiva - 2021 - rua.ua.es
Phosphodiesterase type 5 (PDE5) inhibitors such as Viagra®(sildenafil citrate) have
demonstrated efficacy in the treatment of erectile dysfunction (ED) by inducing cyclic …

Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction

A Laties, I Sharlip - The Journal of Sexual Medicine, 2006 - academic.oup.com
Sildenafil citrate improves erectile function in men with erectile dysfunction (ED) by
selectively inhibiting cyclic guanosine monophosphate (cGMP)‐specific phosphodiesterase …

[HTML][HTML] Visual impairment with possible macular changes after a high dose of sildenafil in a healthy young woman

YY Li, YJ Yu, XP Liu, NP Liu - International Journal of …, 2018 - ncbi.nlm.nih.gov
York, NY, USA), a selective inhibitor of phosphodiesterase type 5 (PDE-5), is widely used for
erectile dysfunction. Its clinical recommended dosage is 25 to 100 mg per day. The most …

Viagra®(sildenafil citrate) and ophthalmology

AM Laties, E Zrenner - Progress in Retinal and Eye Research, 2002 - Elsevier
Viagra®(sildenafil citrate) improves penile erections in men with erectile dysfunction (ED) by
selectively inhibiting cGMP-specific phosphodiesterase type 5 (PDE5), which is present in …

Ocular side effects of sildenafil that persist beyond 24 h—a case series

C Karaarslan - Frontiers in Neurology, 2020 - frontiersin.org
Acute secondary effects of sildenafil, a first-line pharmacotherapy for erectile dysfunction
(ED), include headache, heartburn, skin flush, and vision changes. Generally, these effects …

Are phosphodiesterase type 5 inhibitors associated with vision‐threatening adverse events? A critical analysis and review of the literature

F Azzouni, K Abu Samra - The journal of sexual medicine, 2011 - academic.oup.com
Abstract Introduction Phosphodiesterase type 5 (PDE5) inhibitors are the first line drugs for
treatment of erectile dysfunction. Sildenafil (ViagraR), tadalafil (CialisR), and vardenafil …

Sildenafil in ophthalmology: An update

S Arora, T Surakiatchanukul, T Arora, C Cagini… - Survey of …, 2022 - Elsevier
Sildenafil citrate, a selective oral phosphodiesterase 5 inhibitor, is a widely used drug for
erectile dysfunction that acts by elevating cGMP levels and causing smooth muscle …

Sildenafil citrate induced retinal toxicity—electroretinogram, optical coherence tomography, and adaptive optics findings

F Yanoga, RC Gentile, TYP Chui… - Retinal Cases and …, 2018 - journals.lww.com
Methods: Single retrospective case report. Results: A 31-year-old white man with no medical
history presented with complaints of bilateral multicolored photopsias and erythropsia (red …